A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment.
13-Jun-2018 3:05 PM EDT Add to Favorites
Joan W. Miller, M.D., the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, has been named the 2018 recipient of the...
29-May-2018 1:05 PM EDT Add to Favorites
A research team from Mass. Eye and Ear has shown that the “outer hair cells” within the ear can only be effective in amplifying sound when they are configured in a Y-shaped arrangement with respect to their supporting cells.
10-May-2018 3:05 PM EDT Add to Favorites
Joan W. Miller, M.D., the David Glendenning Cogan Professor and Chair of Ophthalmology at Harvard Medical School and the Chief of Ophthalmology at Massachusetts Eye and Ear and Massachusetts General Hospital, will receive two prestigious awards...
7-May-2018 11:05 AM EDT Add to Favorites
Patricia A. D'Amore, Ph.D., MBA, has been elected to the American Academy of Arts and Sciences for exceptional scholarship in the field of biomedicine.
1-May-2018 11:05 AM EDT Add to Favorites
Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor...
3-Apr-2018 11:45 AM EDT Add to Favorites
Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any...
20-Mar-2018 12:30 PM EDT Add to Favorites
Scientists, Advocates Team Up to Launch Odylia Therapeutics to Accelerate Gene Therapy Trials for Rare Conditions Causing Blindness
New nonprofit organization will bring treatments to clinical trial for people at risk for blindness due to ultra-rare inherited retinal diseases. Boston, Mass. — Scientists and advocates today announced the formation of Odylia Therapeutics, a...
28-Feb-2018 11:05 AM EST Add to Favorites
see all news